Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07102576 · ClinicalTrials.gov registry record · Phase 1
MDMA-Assisted Therapy for Mental Healthcare Providers
A Phase 1 study of Mental Wellbeing, sponsored by Rachel Yehuda.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 30
- Enrollment target
- 1
- Study location
NCT07102576 is a Phase 1 study of Mental Wellbeing that is actively recruiting participants, run by Rachel Yehuda. The registered enrollment target is 30 participants. The trial reports 1 study location across 1 state.
The verdict
NCT07102576, a Phase 1 study of Mental Wellbeing, is actively recruiting participants, sponsored by Rachel Yehuda.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 30 participants
- Enrollment target
- 1
- Study location
Study Summary
This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider self-efficacy, mood, self-compassion, quality of life, and other psychological factors. Participants will work with a co-therapy pair as they engage in a preparatory session, one experimental session with MDMA, and an integration session the following day.
Conditions Studied
Interventions
- DRUG MDMA Hydrochloride
Study Locations (1)
New York
- The Parsons Research Center for Psychedelic Healing - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 30 participants |
| Start Date | 2026-01 |
| Est. Completion | 2029-12-21 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07102576
The ClinicalTrials.gov registry entry for NCT07102576 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 30 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Rachel Yehuda, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Mental Wellbeing appearing as the primary indexed condition, and to 1 intervention - of which MDMA Hydrochloride is the first listed.
NCT07102576 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT07102576 about?
NCT07102576 is a clinical study titled "MDMA-Assisted Therapy for Mental Healthcare Providers". This is a phase 1, open-label study to assess changes in mental well-being following MDMA administration within a therapeutic setting, in mental health providers who are in training to become MDMA assisted therapists. Secondary outcome measures will examine the effects on provider burnout, provider ...
What is the current status of trial NCT07102576?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 30 participants. The study started on 2026-01. Estimated completion is 2029-12-21.
What conditions does trial NCT07102576 study?
This clinical trial studies the following conditions: Mental Wellbeing.
What interventions are being tested in trial NCT07102576?
The interventions under investigation include: MDMA Hydrochloride (DRUG).
Who is sponsoring clinical trial NCT07102576?
This trial is sponsored by Rachel Yehuda, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07102576 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Mental Wellbeing
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.